Amanote Research
Register
Sign In
Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in Tumor Tissues Predicts Poor Survival in Pancreatic Ductal Adenocarcinoma
Bioscience Reports
- Netherlands
doi 10.1042/bsr20182306
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Date
February 1, 2019
Authors
Shu Dong
Fei Huang
Hao Zhang
Qiwen Chen
Publisher
Portland Press Ltd.
Related search
Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma
Cancer
Cancer Research
Oncology
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
International Journal of Medical Sciences
Medicine
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
American Journal of Surgical Pathology
Anatomy
Forensic Medicine
Pathology
Surgery
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
PLoS ONE
Multidisciplinary
Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma
European Journal of Cancer
Cancer Research
Oncology
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
